Operating profit before deduction of amortization: boltbio.com (BOLT)
Bolt Biotherapeutics (BOLT) calculated EBITDA demonstrates the impact of the Boltbody platform on combating metastases in oncology centers. The price rally is driven by the partnership with Roche and new drug trials for stomach cancer treatment. Meanwhile, management is optimizing R&D assets while maintaining balance sheet liquidity. Consequently, 0.00 becomes the new value of the metric, capturing the business's current operational efficiency.
Bolt Biotherapeutics, Inc. (BOLT) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Equity Ratio Bolt Biotherapeutics|BOLT - Long-Term Debt to Capital|Current Liabilities to Capital Bolt Biotherapeutics Inc.|BOLT - Company Aggregate Debts|Debt to Book Capitalization Ratio Bolt Biotherapeutics|BOLT - Company Long-Term Debt|Short-Term Debt Bolt Biotherapeutics|Quick Liquidity boltbio.com
- earnings and multiples data:
BOLT - Net Income|Future Net Profit Bolt Biotherapeutics|BOLT - Price to Earnings Ratio|Future Price to Earnings Multiple Bolt Biotherapeutics Inc.|BOLT - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bolt Biotherapeutics|BOLT - Operating profit EBITDA|Net earnings per share for the last four quarters Bolt Biotherapeutics|BOLT - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months boltbio.com|BOLT - Net earnings per share growth this year|Projected earnings per share increase next year Bolt Biotherapeutics
Summary company analytics:Bolt Biotherapeutics (BOLT)
For Bolt Biotherapeutics (BOLT), which implements robotic automation for molecule screening, the EBITDA_Co indicator serves as a marker of the business's actual ability to generate liquidity. This metric calculates absolute operating profit by excluding depreciation, allowing investors to separate actual cash flow from accounting adjustments and assess the efficiency of current technological investments in laboratory infrastructure.
Competitors of Bolt Biotherapeutics (BOLT)
Operating income before deduction of amortization argenx BVBA (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax S.A. (ABVX) - Operating profit before deduction of amortization|ADMA Biologics, Inc. (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics, Inc.|Operating profit before deduction of amortization IMVT|Operating profit EBITDA Kiniksa Corp|Profit before payment of interest, taxes and amortization Grifols, S.A. (GRFS)|adaptivebiotech.com - Operating profit before amortization|Operating profit EBITDA CLDX (Celldex Therapeutics, Inc.)|Aurinia Pharmaceuticals Inc (AUPH) - Profit before interest, taxes and amortization|BioCryst Pharmaceuticals Inc - Operating profit EBITDA|VERA: Profit before payment of interest, taxes and amortization|Dianthus Therapeutics (DNTH) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization pharvaris.com (PHVS)|Profit before payment of interest, taxes and amortization AbCellera Biologics Inc.|Profit before payment of interest, taxes and amortization TRML|Operating profit before deduction of amortization PGEN (Intrexon)|Company profit before taxes, interest and amortization PHAR|Nektar Therapeutics - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization UPB|Zenas Biopharma - Operating profit EBITDA|IMNM: Profit before payment of interest, taxes and amortization|GOSS: Operating profit EBITDA|KALV - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Septerna Inc|Profit before interest, taxes and amortization pieris.com PVLA|Operating profit before deduction of amortization SVRA (Savara)|Company profit before taxes, interest and amortization RIGL|Operating profit EBITDA ANAB (AnaptysBio Corp)|Income before deduction of interest, taxes and amortization ATXS|enGene Holdings Inc. - Operating profit EBITDA|Profit before interest, taxes and amortization RAPT Therapeutics Inc.|aerovatetx.com (JBIO) - Profit before payment of interest, taxes and amortization|Aclaris Therapeutics Inc. - Income before deduction of interest, taxes and amortization|KYTX (Kyverna) - Operating profit EBITDA|Operating profit EBITDA Tiziana Life Sciences, Ltd.|Profit before payment of interest, taxes and amortization Cabaletta Bio, Inc. (CABA)|VTYX: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA THTX (Theratechnologies)|Avalo Therapeutics, Inc. (AVTX) - Profit before interest, taxes and amortization|ELDN: Operating profit before deduction of amortization|AGEN - Operating profit EBITDA|CLYM (Climb Bio Inc) - Operating profit before deduction of amortization|ZURA: Company profit before taxes, interest and amortization|ATYR (aTyr Pharma) - Operating profit EBITDA|Adagene Corp (ADAG) - Operating income before deduction of amortization|Operating profit EBITDA IMA|Operating profit before deduction of amortization shattucklabs.com STTK|Profit before payment of interest, taxes and amortization Equillium EQ|Operating income before deduction of amortization Connect Biopharma Holdings (CNTB)|Immunic Inc - Operating profit EBITDA|ATRA: Profit before payment of interest, taxes and amortization|inflarx.de (IFRX) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization X4 Pharmaceuticals, Inc (XFOR)|Profit before payment of interest, taxes and amortization Adicet Bio Inc.|Profit before payment of interest, taxes and amortization CELU|Operating profit before deduction of amortization INMB (INmune Bio)|Company profit before taxes, interest and amortization BRNS|Profit before payment of interest, taxes and amortization Kezar Life Sciences, Inc KZR|SABS (SAB Biotherapeutics Inc) - Profit before deduction of interest, taxes, depreciation and amortization|Akari Therapeutics - Operating profit EBITDA|Income before deduction of interest, taxes and amortization ENLV (Enlivex Therapeutics)|QTTB: Operating profit EBITDA|GeoVax Labs (GOVX) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Edesa|IBIO: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Carisma Therapeutics (CARM)|Operating profit before deduction of amortization xtlbio.com XTLB|Operating profit EBITDA HCWB (HCW Biologics)|Operating profit EBITDA Aptevo Therapeutics, Inc. APVO|AIM: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization ADTX (Aditxt)|GRI: Operating profit EBITDA|XRTX - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Vyome Holdings|Operating profit before deduction of amortization Revelation Biosciences Inc (REVB)|Profit before payment of interest, taxes and amortization Indaptus (INDP)|Operating profit before deduction of amortization BiondVax Pharmaceuticals SCNI|CalciMedica - Operating profit before deduction of amortization|Operating profit EBITDA Affimed NV AFMD|ALLK - Profit before payment of interest, taxes and amortization|HOOK (HOOKIPA Pharma Inc.) - Operating profit before amortization|IGMS: Operating profit EBITDA|Profit before interest, taxes and amortization iTeos Pharma (ITOS)|OCEA (Ocean Biomedical, Inc.) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization TCBP|Profit before payment of interest, taxes and amortization Third Harmonic Bio, Inc. (THRD)
